305 related articles for article (PubMed ID: 17309338)
21. Thrombotic thrombocytopenic purpura-what is new?
Shah N; Sarode R
J Clin Apher; 2013 Feb; 28(1):30-5. PubMed ID: 23420593
[TBL] [Abstract][Full Text] [Related]
22. Current concepts in thrombotic thrombocytopenic purpura.
Tsai HM
Annu Rev Med; 2006; 57():419-36. PubMed ID: 16409158
[TBL] [Abstract][Full Text] [Related]
23. [Successful treatment with rituximab in a patient with refractory thrombotic thrombocytopenic purpura refractory to plasma exchange].
Koshino M; Kudou D; Okoshi Y; Obara N; Simizu S; Mukai HY; Suzukawa K; Hasegawa Y; Kojima H; Nagasawa T; Chiba S
Rinsho Ketsueki; 2010 Feb; 51(2):127-31. PubMed ID: 20379104
[TBL] [Abstract][Full Text] [Related]
24. A 9-month-old infant with acquired idiopathic thrombotic thrombocytopenic purpura caused by inhibitory IgG-autoantibody to ADAMTS13.
Sato A; Hoshi Y; Onuma M; Sato R; Tsunematsu Y; Isonishi A; Matsumoto M; Fujimura Y; Imaizumi M
Pediatr Hematol Oncol; 2010 Feb; 27(1):53-8. PubMed ID: 20121555
[TBL] [Abstract][Full Text] [Related]
25. Rituximab as preventive therapy of a clinical relapse in TTP with ADAMTS13 inhibitor.
Schleinitz N; Ebbo M; Mazodier K; Poullin P; Bernit E; Veit V; Veyradier A; Fakhouri F; Kaplanski G; Harle JR
Am J Hematol; 2007 May; 82(5):417-8. PubMed ID: 17266057
[No Abstract] [Full Text] [Related]
26. [Rituximab provided long-term remission in a patient with severe thrombotic thrombocytopenic purpura refractory to plasma exchange].
Hong H; Aoyama Y; Yamamura R; Ohta T; Mugitani A; Yamane T; Hino M; Matsumoto M; Fujimura Y
Rinsho Ketsueki; 2006 Dec; 47(12):1528-32. PubMed ID: 17233471
[TBL] [Abstract][Full Text] [Related]
27. Rituximab for acute plasma-refractory thrombotic thrombocytopenic purpura. A case report and concise review of the literature.
Rüfer A; Brodmann D; Gregor M; Kremer Hovinga JA; Lämmle B; Wuillemin WA
Swiss Med Wkly; 2007 Sep; 137(37-38):518-24. PubMed ID: 17990141
[TBL] [Abstract][Full Text] [Related]
28. Relapsing or refractory idiopathic thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the role of rituximab.
Caramazza D; Quintini G; Abbene I; Malato A; Saccullo G; Lo Coco L; Di Trapani R; Palazzolo R; Barone R; Mazzola G; Rizzo S; Ragonese P; Aridon P; Abbadessa V; Siragusa S
Transfusion; 2010 Dec; 50(12):2753-60. PubMed ID: 20576013
[TBL] [Abstract][Full Text] [Related]
29. Atypical presentations of thrombotic thrombocytopenic purpura: a review.
Sarode R
J Clin Apher; 2009; 24(1):47-52. PubMed ID: 19073011
[TBL] [Abstract][Full Text] [Related]
30. Practical issues in ADAMTS13 testing and emerging therapies in thrombotic thrombocytopenic purpura.
Cataland SR; Wu HM
Semin Hematol; 2011 Oct; 48(4):242-50. PubMed ID: 22000089
[TBL] [Abstract][Full Text] [Related]
31. Rituximab in a child with autoimmune thrombotic thrombocytopenic purpura refractory to plasma exchange.
Narayanan P; Jayaraman A; Rustagi RS; Mahadevan S; Parameswaran S
Int J Hematol; 2012 Jul; 96(1):122-4. PubMed ID: 22552883
[TBL] [Abstract][Full Text] [Related]
32. Rituximab can be combined with daily plasma exchange to achieve effective B-cell depletion and clinical improvement in acute autoimmune TTP.
Darabi K; Berg AH
Am J Clin Pathol; 2006 Apr; 125(4):592-7. PubMed ID: 16627268
[TBL] [Abstract][Full Text] [Related]
33. Acquired, noncongenital thrombotic thrombocytopenic purpura in children and adolescents: clinical management and the use of ADAMTS 13 assays.
McDonald V; Liesner R; Grainger J; Gattens M; Machin SJ; Scully M
Blood Coagul Fibrinolysis; 2010 Apr; 21(3):245-50. PubMed ID: 20083997
[TBL] [Abstract][Full Text] [Related]
34. Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13.
Scully M; Cohen H; Cavenagh J; Benjamin S; Starke R; Killick S; Mackie I; Machin SJ
Br J Haematol; 2007 Feb; 136(3):451-61. PubMed ID: 17233847
[TBL] [Abstract][Full Text] [Related]
35. Rituximab prevents recurrence of thrombotic thrombocytopenic purpura: a case report.
Galbusera M; Bresin E; Noris M; Gastoldi S; Belotti D; Capoferri C; Daina E; Perseghin P; Scheiflinger F; Fakhouri F; Grünfeld JP; Pogliani E; Remuzzi G
Blood; 2005 Aug; 106(3):925-8. PubMed ID: 15827129
[TBL] [Abstract][Full Text] [Related]
36. Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases.
Fakhouri F; Vernant JP; Veyradier A; Wolf M; Kaplanski G; Binaut R; Rieger M; Scheiflinger F; Poullin P; Deroure B; Delarue R; Lesavre P; Vanhille P; Hermine O; Remuzzi G; Grünfeld JP
Blood; 2005 Sep; 106(6):1932-7. PubMed ID: 15933059
[TBL] [Abstract][Full Text] [Related]
37. Successful treatment with rituximab for acute refractory thrombotic thrombocytopenic purpura related to acquired ADAMTS13 deficiency: a pediatric report and literature review.
Harambat J; Lamireau D; Delmas Y; Ryman A; Llanas B; Brissaud O
Pediatr Crit Care Med; 2011 Mar; 12(2):e90-3. PubMed ID: 20625343
[TBL] [Abstract][Full Text] [Related]
38. Refractory thrombotic thrombocytopenic purpura in a 16-year-old girl: successful treatment with bortezomib.
van Balen T; Schreuder MF; de Jong H; van de Kar NC
Eur J Haematol; 2014 Jan; 92(1):80-2. PubMed ID: 24118335
[TBL] [Abstract][Full Text] [Related]
39. Acquired thrombotic thrombocytopenic purpura due to antibody-mediated ADAMTS13 deficiency precipitated by a localized Castleman's disease: a case report.
Benevides TC; Orsi FA; Colella MP; Percout Pde O; Moura MS; Dias MA; Lins BD; Paula EV; Vassallo J; Annichino-Bizzachi J
Platelets; 2015; 26(3):263-6. PubMed ID: 24853254
[TBL] [Abstract][Full Text] [Related]
40. Recent advances in thrombotic thrombocytopenic purpura.
Sadler JE; Moake JL; Miyata T; George JN
Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
